- V-BID Center Infographic: Clinical and Equity Implications of Braidwood v. Becerra
- Limited Upside for Employers to Resume Cost-Sharing on Preventive Services
- Diverse Group of HCOs Support Government’s Effort to Reverse Braidwood v. Becerra
- Patients May Miss Out on Free Coverage of Cancer Screenings and Vaccinations
- Better Care Associated with Medicaid Expansion [...]
- R. 3800: Chronic Disease Flexible Coverage Act
- EBRI Report: Implications of Braidwood v. Becerra
- Preventive Services Still in Place after Court Agreement
- Are We Any Closer to V-BID X?
- Health Insurers Play a Key Role in Health Equity
- Nebraska Limits Insulin Costs [...]
- Brief: Clinical and Equity Implications of Braidwood v. Becerra
- Use of ACA Preventive Care Potentially Affected by Braidwood v. Becerra
-Braidwood v. Becerra Webinar
-Preventive Care Coverage at a Crossroads
-2% of Adults Reported Not Taking Medication as Prescribed Due to Cost
- Patient Groups Support Court of Appeals Decision to Stay Braidwood v. Becerra Ruling
- Court Decision Could Lead to More than 22 Million Women Losing Access to Mammogram Screenings
- Most Employers Intend to Keep Preventive Services Even after Texas ACA Ruling
- AHCJ Webinar Recording Available: Covering the Lawsuit That Could Limit Free Preventive Care
- Upcoming Event: Braidwood v. Becerra Webinar [...]
- Clinical Implications of The Braidwood Ruling: Use of Pre-ACA Task Force Recommendations
- Webinar: Covering the Lawsuit That Could Limit Free Preventive Care
- Fact Sheet: Braidwood v. Becerra Case on Preventive Services
- Over 1 in 5 Skip Health Care Due to Transportation Barriers
- Advancing Health Technology Assessment Methods that Support Health Equity [...]
- NPR’s On Point Highlights Court Ruling Striking Down ACA’s Preventive Service Provisions
- Justice Department Seeks Stay on Parts of ACA Preventive Services Ruling
- ACA Frequently Asked Questions Addresses Braidwood Ruling
- Insurers Say Free Preventive Care Will Continue While Lawsuit is Appealed
- CMMI Publishes Medicare Advantage V-BID Model Fact Sheet [...]
- ACA Preventive Services Mandate Struck Down by Federal Judge
- Governor Whitmer Takes Action to Protect Coverage for Preventive Healthcare
- 6 in 10 Consumers with Private Insurance Use No-Cost Preventive Services
- Ruling to Block ACA Requirement for No-Cost Preventive Care Is Unpopular
- Patient Cost Exposure and Use of Preventive Care Among Individual Plans [...]
- Watch the 2023 V-BID Summit Recording
- Medicare Advantage Value-Based Insurance Design (V-BID) Model to be Extended
- Bipartisan Bill Expands Pre-Deductible Coverage For Chronic Disease Management
- Implications of Braidwood v. Becerra Ruling for Health Care Consumers
- V-BID Program Boosted Primary Care Use and Contained Healthcare Costs [...]
- Register Now – 2023 Virtual V-BID Summit
- Chronic Disease Management Act Re-Introduced in Congress
- Bipartisan Bill Would Require Copay Assistance to Count Toward Out-of-Pocket Costs
- New V-BID Center Brief: Reducing No-Value Care to Enhance Health Equity
- No Value Without Equity: Action Opportunities Emerging from the IVI Health Equity Initiative [...]
- Register Now – 2023 Virtual V-BID Summit
- The Administration’s Next Crack at Lower Drug Prices
- Value-Based Insurance Design is Driving Change in Healthcare
- Value-Based Care: What It Is, and Why It’s Needed
- Designing A Value-Based Formulary for a Commercial Health Plan [...]
- Register Now: 2023 Virtual V-BID Summit
- Racial And Ethnic Disparities Among Medicare Beneficiaries
- Financing Health Care System Interventions Addressing Social Risks
- USofCare Report Encourages States to Advance Equity Through Health Coverage
- New Proposed Rules to Expand Access to Birth Control Coverage Under the ACA
- Insulin Affordability and the Inflation Reduction Act [...]
Registration is now open for the V-BID Center's 2023 virtual summit
Healthcare Spending, Medicaid and Private Plans Innovate to Accelerate Equity
Holiday Newsletter, 2023 V-BID Center Summit
Out of Pocket Costs Remain a Burden for Patients; Millions Spent on Low-Value Cancer Screening
